FORMYCON AG
ItalyAll drugs from this manufacturer
-
This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.
Dosage form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
-
This medicine is injected into the eye to treat several vision diseases in adults, including age-related neovascular macular degeneration, macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.
Dosage form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
-
Fymskina is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in pre-filled syringe
Active substance Dosage ustekinumab - ATC: L04AC05